Results 161 to 170 of about 4,696 (201)
Some of the next articles are maybe not open access.
Antitrypanosomal Therapy for Chronic Chagas' Disease
New England Journal of Medicine, 2011A 42-year-old woman presents after donating blood and receiving a report that she is positive for Chagas' disease. Chagas' disease is caused by a parasite and is endemic in many parts of Latin America.
Facundo, Garcia-Bournissen +1 more
openaire +5 more sources
Antileishmanial and antitrypanosomal drug identification
Emerging Topics in Life Sciences, 2017Although the treatments for human African trypanosomiasis (HAT), leishmaniasis and Chagas disease (CD) still rely on drugs developed several decades ago, there has been significant progress in the identification, development and use of novel drugs and formulations. Notably, there are now two drugs in clinical trial for HAT, fexinidazole and acoziborole;
Simon L, Croft +2 more
openaire +2 more sources
Antitrypanosomal and Antileishmanial Activities
2018The so-called neglected tropical diseases, which are endemic in 149 tropical and subtropical countries, affect more than 1 billion people annually, including 875 million children in developing economies. These diseases are responsible for over 500,000 deaths per year and are characterized by long-term disability and severe pain.
Sanchez Alberti, Andrés +3 more
openaire +2 more sources
Antitrypanosomal Agents: Treatment or Threat?
Lancet, The, 2010768 www.thelancet.com Vol 376 September 4, 2010 Authors’ reply Allergic dermatitis, the most common adverse eff ect of benznidazole, is selflimiting, usually of mild-to-moderate intensity, easily manageable with corticosteroids, and in most patients does not require interruption of therapy.
Victor Sarli Issa, Edimar Alcides Bocchi
exaly +2 more sources
Antitrypanosomal Lactones from Nectandra barbellata
Journal of Natural Products, 2021Twigs of Nectandra barbellata were extracted using a solution of the ionic liquid 1-butyl-3-methylimidazolium bromide (BMImBr) in H2O, assisted by microwave (MAE). After successive chromatographic steps, one sesquiterpene, costic acid, and three new related lactones, (R)-3(7)-Z-3-hexadec-21-enylidene-5-(hydroxymethyl)tetrahydrofuran-2-one (1), (R)-3(7)-
Vinicius S. Londero +9 more
openaire +2 more sources
2-Arylpaullones are selective antitrypanosomal agents
European Journal of Medicinal Chemistry, 2013Antileishmanial paullone-chalcone hybrid molecules display antiparasitic activity against Trypanosoma brucei rhodesiense blood stream forms, albeit with low selectivity against human THP-1 cells. In order to develop less toxic analogues, paullones with acrylamide or aryl substituents in 2-position were synthesized, of which the latter exhibited potent ...
Jasmin, Ryczak +7 more
openaire +2 more sources
Antitrypanosomal activity of quaternary naphthalimide derivatives
Bioorganic & Medicinal Chemistry Letters, 2007Sleeping sickness caused by Trypanosoma brucei gambiense and rhodesiense is fatal if left untreated. Due to the toxicity of drugs currently used and the emerging resistance against these drugs new lead compounds are urgently needed. Within the frame of a broad screening program for drugs with antitrypanosomal activity, some highly potent tertiary and ...
Mathias, Muth +6 more
openaire +2 more sources
Antitrypanosomal Cycloartane Glycosides fromAstragalus baibutensis
Chemistry & Biodiversity, 2006Baibutoside (5), a new cycloartane-type triterpene glycoside, has been isolated from the roots of Astragalus baibutensis along with four known glycosides, acetylastragaloside I (1), and astragalosides I, II, and IV (2-4, resp.). The structure elucidation of the compounds were achieved by a combination of one- and two-dimensional NMR techniques (DQF ...
Ihsan, Caliş +5 more
openaire +2 more sources
Trypanothione as a Target in the Design of Antitrypanosomal and Antileishmanial Agents
Current Pharmaceutical Design, 2001Trypanothione is the key molecule in the defence mechanism of Trypanosoma and Leishmania against oxidative stress. The uniqueness of trypanothione makes the metabolism of this molecule an attractive target in antitrypanosomal and antileishmanial drug design. It became clear that this antioxidant cascade can be considered as the "Achilles heel" of these
Augustyns, K. +4 more
openaire +3 more sources
Prolylisoxazoles: Potent Inhibitors of Prolyloligopeptidase with Antitrypanosomal Activity.
ChemInform, 2003AbstractFor Abstract see ChemInform Abstract in Full Text.
Bal, Gunther +7 more
openaire +4 more sources

